title: Comparison between anthelmintic treatment strategies against Ascaridia galli in commercial laying hens.
abstract: The efficacy of a sustainable deworming strategy based on targeted treatments (TT) against Ascaridia galli was investigated for the first time in laying hen flocks on a Swedish commercial farm. Three experimental protocols with different levels of treatment, e.g. targeted treatment (TT), conventional treatment (CT) and untreated (UT), were tested in randomly allocated flocks of two different bird hybrids. Every second week faecal egg counts (FECs) were determined from pooled faecal materials collected on trays (20×27cm) placed for a maximum of 12h on the litter belts. In the TT, anthelmintic administration (fenbendazole, 1mg/kg body weight for 5days) started at 22 weeks post placement (wpp) and was repeated twice when the pooled FECs surpassed the assigned threshold of 200 egg per gram faeces (EPG). The CT flocks were treated once at 27wpp using the same anthelmintic. Hens in the UT were not dewormed and served as controls. Additionally, FECs on cloacal contents, worm fecundity and worm burdens were determined at 19, 35 and 45wpp. None of the flocks became infected until after 16wpp. The cumulative pooled FECs at the end of the study were significantly (p<0.01) lower in the TT compared to both CT and UT. Although repeated treatment in the TT protocol did not affect the fecundity, a worm density-dependent increase in fecundity was observed. Cloacal FECs and the number of adult A. galli in TT at 35 and 45wpp were significantly lower compared to other flocks. This study provides evidence that the TT strategy is better in terms of lower worm burden and decreased cumulative environmental parasite egg numbers compared to CT strategy. The TT strategy should be considered as an alternative to the CT strategy with regard to A. galli control in commercial laying hens.
authors: Department of Biomedical Sciences and Veterinary Public Health, Section for Parasitology, Swedish University of Agricultural Sciences (SLU), P.O. Box 7036, SE-750 07, Uppsala, Sweden. Electronic address: behdad.tarbiat@slu.se.
authors: B
authors: B
authors: Tarbiat
authors: Department of Animal Health and Antimicrobial Strategies, National Veterinary Institute (SVA), SE-751 89, Uppsala, Sweden.
authors: D S
authors: DS
authors: Jansson
authors: Department of Biomedical Sciences and Veterinary Public Health, Section for Parasitology, Swedish University of Agricultural Sciences (SLU), P.O. Box 7036, SE-750 07, Uppsala, Sweden.
authors: E
authors: E
authors: Tydén
authors: Department of Biomedical Sciences and Veterinary Public Health, Section for Parasitology, Swedish University of Agricultural Sciences (SLU), P.O. Box 7036, SE-750 07, Uppsala, Sweden.
authors: J
authors: J
authors: Höglund
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001197:Ascaridia / Q000187:drug effects* / Q000502:physiology; D001198:Ascaridiasis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D002645:Chickens / Q000469:parasitology*; D002988:Cloaca / Q000469:parasitology; D005243:Feces / Q000469:parasitology; D005260:Female; D005298:Fertility / Q000187:drug effects; D007422:Intestines / Q000469:parasitology; D008297:Male; D010270:Parasite Egg Count / Q000662:veterinary; D011201:Poultry Diseases / Q000188:drug therapy* / Q000469:parasitology
chemical_list: D000871:Anthelmintics
keywords: Ascaridia galli; Deworming; Fenbendazole; Larvae; Parasite egg; Targeted treatment